Cargando…
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis accordin...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205996/ https://www.ncbi.nlm.nih.gov/pubmed/33831308 http://dx.doi.org/10.1161/CIRCGEN.120.003273 |
_version_ | 1783708562409652224 |
---|---|
author | James, Cynthia A. Jongbloed, Jan D.H. Hershberger, Ray E. Morales, Ana Judge, Daniel P. Syrris, Petros Pilichou, Kalliopi Domingo, Argelia Medeiros Murray, Brittney Cadrin-Tourigny, Julia Lekanne Deprez, Ronald Celeghin, Rudy Protonotarios, Alexandros Asatryan, Babken Brown, Emily Jordan, Elizabeth McGlaughon, Jennifer Thaxton, Courtney Kurtz, C. Lisa van Tintelen, J. Peter |
author_facet | James, Cynthia A. Jongbloed, Jan D.H. Hershberger, Ray E. Morales, Ana Judge, Daniel P. Syrris, Petros Pilichou, Kalliopi Domingo, Argelia Medeiros Murray, Brittney Cadrin-Tourigny, Julia Lekanne Deprez, Ronald Celeghin, Rudy Protonotarios, Alexandros Asatryan, Babken Brown, Emily Jordan, Elizabeth McGlaughon, Jennifer Thaxton, Courtney Kurtz, C. Lisa van Tintelen, J. Peter |
author_sort | James, Cynthia A. |
collection | PubMed |
description | BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis according to the 2010 Task Force Criteria. As incorrect attribution of a gene to ARVC can contribute to misdiagnosis, we assembled an international multidisciplinary ARVC Clinical Genome Resource Gene Curation Expert Panel to reappraise all reported ARVC genes. METHODS: Following a comprehensive literature search, six 2-member teams conducted blinded independent curation of reported ARVC genes using the semiquantitative Clinical Genome Resource framework. RESULTS: Of 26 reported ARVC genes, only 6 (PKP2, DSP, DSG2, DSC2, JUP, and TMEM43) had strong evidence and were classified as definitive for ARVC causation. There was moderate evidence for 2 genes, DES and PLN. The remaining 18 genes had limited or no evidence. RYR2 was refuted as an ARVC gene since clinical data and model systems exhibited a catecholaminergic polymorphic ventricular tachycardia phenotype. In ClinVar, only 5 pathogenic/likely pathogenic variants (1.1%) in limited evidence genes had been reported in ARVC cases in contrast to 450 desmosome gene variants (97.4%). CONCLUSIONS: Using the Clinical Genome Resource approach to gene-disease curation, only 8 genes (PKP2, DSP, DSG2, DSC2, JUP, TMEM43, PLN, and DES) had definitive or moderate evidence for ARVC, and these genes accounted for nearly all pathogenic/likely pathogenic ARVC variants in ClinVar. Therefore, only pathogenic/likely pathogenic variants in these 8 genes should yield a major criterion for ARVC diagnosis. Pathogenic/likely pathogenic variants identified in other genes in a patient should prompt further phenotyping as variants in many of these genes are associated with other cardiovascular conditions. |
format | Online Article Text |
id | pubmed-8205996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-82059962021-06-16 International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework James, Cynthia A. Jongbloed, Jan D.H. Hershberger, Ray E. Morales, Ana Judge, Daniel P. Syrris, Petros Pilichou, Kalliopi Domingo, Argelia Medeiros Murray, Brittney Cadrin-Tourigny, Julia Lekanne Deprez, Ronald Celeghin, Rudy Protonotarios, Alexandros Asatryan, Babken Brown, Emily Jordan, Elizabeth McGlaughon, Jennifer Thaxton, Courtney Kurtz, C. Lisa van Tintelen, J. Peter Circ Genom Precis Med Original Articles BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis according to the 2010 Task Force Criteria. As incorrect attribution of a gene to ARVC can contribute to misdiagnosis, we assembled an international multidisciplinary ARVC Clinical Genome Resource Gene Curation Expert Panel to reappraise all reported ARVC genes. METHODS: Following a comprehensive literature search, six 2-member teams conducted blinded independent curation of reported ARVC genes using the semiquantitative Clinical Genome Resource framework. RESULTS: Of 26 reported ARVC genes, only 6 (PKP2, DSP, DSG2, DSC2, JUP, and TMEM43) had strong evidence and were classified as definitive for ARVC causation. There was moderate evidence for 2 genes, DES and PLN. The remaining 18 genes had limited or no evidence. RYR2 was refuted as an ARVC gene since clinical data and model systems exhibited a catecholaminergic polymorphic ventricular tachycardia phenotype. In ClinVar, only 5 pathogenic/likely pathogenic variants (1.1%) in limited evidence genes had been reported in ARVC cases in contrast to 450 desmosome gene variants (97.4%). CONCLUSIONS: Using the Clinical Genome Resource approach to gene-disease curation, only 8 genes (PKP2, DSP, DSG2, DSC2, JUP, TMEM43, PLN, and DES) had definitive or moderate evidence for ARVC, and these genes accounted for nearly all pathogenic/likely pathogenic ARVC variants in ClinVar. Therefore, only pathogenic/likely pathogenic variants in these 8 genes should yield a major criterion for ARVC diagnosis. Pathogenic/likely pathogenic variants identified in other genes in a patient should prompt further phenotyping as variants in many of these genes are associated with other cardiovascular conditions. Lippincott Williams & Wilkins 2021-04-08 /pmc/articles/PMC8205996/ /pubmed/33831308 http://dx.doi.org/10.1161/CIRCGEN.120.003273 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Articles James, Cynthia A. Jongbloed, Jan D.H. Hershberger, Ray E. Morales, Ana Judge, Daniel P. Syrris, Petros Pilichou, Kalliopi Domingo, Argelia Medeiros Murray, Brittney Cadrin-Tourigny, Julia Lekanne Deprez, Ronald Celeghin, Rudy Protonotarios, Alexandros Asatryan, Babken Brown, Emily Jordan, Elizabeth McGlaughon, Jennifer Thaxton, Courtney Kurtz, C. Lisa van Tintelen, J. Peter International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title | International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title_full | International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title_fullStr | International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title_full_unstemmed | International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title_short | International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework |
title_sort | international evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205996/ https://www.ncbi.nlm.nih.gov/pubmed/33831308 http://dx.doi.org/10.1161/CIRCGEN.120.003273 |
work_keys_str_mv | AT jamescynthiaa internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT jongbloedjandh internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT hershbergerraye internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT moralesana internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT judgedanielp internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT syrrispetros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT pilichoukalliopi internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT domingoargeliamedeiros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT murraybrittney internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT cadrintourignyjulia internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT lekannedeprezronald internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT celeghinrudy internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT protonotariosalexandros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT asatryanbabken internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT brownemily internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT jordanelizabeth internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT mcglaughonjennifer internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT thaxtoncourtney internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT kurtzclisa internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework AT vantintelenjpeter internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework |